HOCPCA Exerts Neuroprotection on Retinal Ganglion Cells by Binding to CaMKIIα and Modulating Oxidative Stress and Neuroinflammation in Experimental Glaucoma
机构：[1]Department of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne 50937, Germany [2]Key Laboratory of Yunnan Province, Yunnan Eye Institute, Afliated Hospital of Yunnan University, Yunnan University, Kunming 650021, China [3]Department of Orthopedics, The First People’s Hospital of Yunnan Province, Kunming 650032, China 外科片骨科云南省第一人民医院[4]The Afliated Hospital of Kunming University of Science and Technology, Kunming 650032, China [5]Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne 50935, Germany [6]Cologne Cluster of Excellence on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne 50931, Germany [7]Molecular and Translational Neurosciences, CECAD Cluster of Excellence, CMMC Center of Molecular Medicine Cologne, University of Cologne, Cologne 50931, Germany
Neuronal injury in glaucoma persists despite effective intraocular pressure (IOP) control, necessitating neuroprotective strategies for retinal ganglion cells (RGCs). In this study, we investigated the neuroprotective role of the gamma-hydroxybutyrate analog HOCPCA in a glaucoma model, focusing on its effects on CaMKII signaling, oxidative stress, and neuroinflammatory responses. Retinal tissue from high IOP animal models was analyzed via proteomics. In vitro mouse retinal explants were subjected to elevated pressure and oxidative stress, followed by HOCPCA treatment. HOCPCA significantly mitigated the RGC loss induced by oxidative stress and elevated pressure, preserving neuronal function. It restored CaMKII alpha and beta levels, preserving RGC integrity, while also modulating oxidative stress and neuroinflammatory responses. These findings suggest that HOCPCA, through its interaction with CaMKII, holds promise as a neuroprotective therapy for glaucoma.
基金：
China Scholarship Council; Forschungsfoerderung 2022 of the Sektion der Deutschen Ophthalmologischen Gesellschaft (DOG)-Glaucoma; State of North-Rhine-Westphalia, Germany [AZ: 323-8.04.10.02-141905]; German Center for Infection Research, DZIF [TTU 08.927, TTU 08.928]; Deutsche Forschungsgemeinschaft (DFG) [PR1569/1-1, PR 1569/1-3]; Projekt DEAL
第一作者机构：[1]Department of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne 50937, Germany [2]Key Laboratory of Yunnan Province, Yunnan Eye Institute, Afliated Hospital of Yunnan University, Yunnan University, Kunming 650021, China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Li Panpan,Shi Xin,Liu Hanhan,et al.HOCPCA Exerts Neuroprotection on Retinal Ganglion Cells by Binding to CaMKIIα and Modulating Oxidative Stress and Neuroinflammation in Experimental Glaucoma[J].NEUROSCIENCE BULLETIN.2025,doi:10.1007/s12264-025-01417-0.
APA：
Li, Panpan,Shi, Xin,Liu, Hanhan,Feng, Yuan,Wang, Xiaosha...&Prokosch, Verena.(2025).HOCPCA Exerts Neuroprotection on Retinal Ganglion Cells by Binding to CaMKIIα and Modulating Oxidative Stress and Neuroinflammation in Experimental Glaucoma.NEUROSCIENCE BULLETIN,,
MLA：
Li, Panpan,et al."HOCPCA Exerts Neuroprotection on Retinal Ganglion Cells by Binding to CaMKIIα and Modulating Oxidative Stress and Neuroinflammation in Experimental Glaucoma".NEUROSCIENCE BULLETIN .(2025)
